Jéssica Rodrigues - Epidemiology

Author Information

Jessica Rodrigues is affiliated with the Department of Epidemiology at the Portuguese Oncology Institute of Porto, located in Porto, Portugal. Her research work primarily focuses on oncology and epidemiology, with a particular interest in cancer treatment and screening methodologies.

Research Contributions

Jessica Rodrigues has significantly contributed to the field of oncology, particularly in understanding the treatment and epidemiology of various cancers. Her research work includes the evaluation of treatment sequences for metastatic colorectal cancer, the development of diagnostic panels for renal cell carcinoma, and real-world evidence research in melanoma. Furthermore, she has analyzed the impact of the COVID-19 pandemic on cancer diagnosis, treatment, and screening, with a focus on the Northern Portugal region. Her studies are pivotal in forming the basis for improved cancer management and screening programs.

Aliases

Jessica Rodrigues is also known by the aliases J Rodrigues and Jéssica Rodrigues.

Publication and Citation Metrics

Metric	Count
Citation Count	287
H-index	7
Paper Count	15

Publications:

Evaluating the Optimal Sequence of Treatment With EGFR Inhibitors and Bevacizumab in RAS Wild-Type Metastatic Colorectal Cancer

DOI: 10.7759/cureus.23543

Year: 2022

LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma

DOI: 10.3390/cancers14040858

Year: 2022

Comprehensive real-world evidence research in stage III and IV melanoma: Evaluation of a cohort of patients treated at a Portuguese institution.

DOI: 10.1200/JCO.2021.39.15_SUPPL.E18774

Year: 2021

Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.

DOI: 10.1016/S1470-2045(21)00199-6

Year: 2021

Demographic, clinical and pathological characterisation of patients with colorectal and anal cancer followed between 2013 and 2016 at Maputo Central Hospital, Mozambique

DOI: 10.3332/ecancer.2021.1205

Year: 2021

The impact of the COVID‐19 pandemic on the short‐term survival of patients with cancer in Northern Portugal

DOI: 10.1002/ijc.33532

Year: 2021

Performance of DNA methylation‐based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study

DOI: 10.1002/ijc.33778

Year: 2021

The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal

DOI: 10.1097/CEJ.0000000000000686

Year: 2021

The impact of the COVID-19 pandemic on cancer screening.

DOI: 10.1097/CEJ.0000000000000720

Year: 2021

Development of a preoperative risk score on admission in surgical intermediate care unit in gastrointestinal cancer surgery

DOI: 10.1186/s13741-020-00151-7

Year: 2020

What Are Collision-Related Injuries?

Why is 'Person' an Important Factor in Epidemiological Studies?

What are the Legal Implications of Misconduct in Epidemiology?

How is Broth Media Used in Disease Surveillance?

What are Sleep Disturbances?

What is Study Validity?

How is a Propagated Outbreak Identified?

What Are the Common Types of Tumors?

How Can the Spread of Antibiotic Resistance Genes be Controlled?

How Does Diagnostic Stewardship Work?

Partnered Content Networks

Relevant Topics